Log in

NASDAQ:BWAY - BRAINSWAY LTD/S Stock Price, Forecast & News

$10.44
+0.07 (+0.68 %)
(As of 12/16/2019 07:56 AM ET)
Today's Range
$10.42
Now: $10.44
$10.44
50-Day Range
$8.35
MA: $9.38
$10.83
52-Week Range
$8.00
Now: $10.44
$12.39
Volume606 shs
Average Volume15,764 shs
Market Capitalization$112.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive compulsive disorders, and stroke rehabilitation. Brainsway Ltd. was founded in 2003 and is based in Jerusalem, Israel.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BWAY
CUSIPN/A
CIKN/A
Phone972-2581-3140

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees96
Market Cap$112.95 million
Next Earnings DateN/A
OptionableNot Optionable

Receive BWAY News and Ratings via Email

Sign-up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter.


BRAINSWAY LTD/S (NASDAQ:BWAY) Frequently Asked Questions

What is BRAINSWAY LTD/S's stock symbol?

BRAINSWAY LTD/S trades on the NASDAQ under the ticker symbol "BWAY."

What price target have analysts set for BWAY?

5 analysts have issued 1-year price targets for BRAINSWAY LTD/S's shares. Their forecasts range from $13.00 to $19.00. On average, they expect BRAINSWAY LTD/S's share price to reach $16.50 in the next year. This suggests a possible upside of 58.1% from the stock's current price. View Analyst Price Targets for BRAINSWAY LTD/S.

What is the consensus analysts' recommendation for BRAINSWAY LTD/S?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BRAINSWAY LTD/S in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BRAINSWAY LTD/S.

Has BRAINSWAY LTD/S been receiving favorable news coverage?

Media stories about BWAY stock have been trending somewhat negative on Monday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BRAINSWAY LTD/S earned a news sentiment score of -1.7 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for BRAINSWAY LTD/S.

Who are some of BRAINSWAY LTD/S's key competitors?

What other stocks do shareholders of BRAINSWAY LTD/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BRAINSWAY LTD/S investors own include Neuronetics (STIM), Wix.Com (WIX), Amarin (AMRN), Cara Therapeutics (CARA), Corbus Pharmaceuticals (CRBP), HEXO (HEXO), Micron Technology (MU), Uniqure (QURE), Verastem (VSTM) and Square (SQ).

Who are BRAINSWAY LTD/S's key executives?

BRAINSWAY LTD/S's management team includes the folowing people:
  • Dr. David Zacut, Founder & Chairman (Age 66)
  • Prof. Abraham Zangen, Founder & Member of the Scientific Advisory Board (Age 49)
  • Dr. Yiftach Roth, Founder & Chief Scientist (Age 48)
  • Mr. Hadar Levy, Chief Financial Officer (Age 45)
  • Mr. Ronen Segal, Chief Technology Officer (Age 46)

When did BRAINSWAY LTD/S IPO?

(BWAY) raised $30 million in an initial public offering (IPO) on Wednesday, April 17th 2019. The company issued 2,500,000 shares at $11.94 per share. Cantor acted as the underwriter for the IPO.

Who are BRAINSWAY LTD/S's major shareholders?

BRAINSWAY LTD/S's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Phoenix Holdings Ltd. (2.87%).

Which major investors are buying BRAINSWAY LTD/S stock?

BWAY stock was bought by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd..

How do I buy shares of BRAINSWAY LTD/S?

Shares of BWAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is BRAINSWAY LTD/S's stock price today?

One share of BWAY stock can currently be purchased for approximately $10.44.

How big of a company is BRAINSWAY LTD/S?

BRAINSWAY LTD/S has a market capitalization of $112.95 million. BRAINSWAY LTD/S employs 96 workers across the globe.View Additional Information About BRAINSWAY LTD/S.

What is BRAINSWAY LTD/S's official website?

The official website for BRAINSWAY LTD/S is http://www.brainsway.com/.

How can I contact BRAINSWAY LTD/S?

BRAINSWAY LTD/S's mailing address is 19 HARTUM STREET BYNET BUILDING 3RD FL, Jerusalem L3, 91451. The company can be reached via phone at 972-2581-3140 or via email at [email protected]


MarketBeat Community Rating for BRAINSWAY LTD/S (NASDAQ BWAY)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about BRAINSWAY LTD/S and other stocks. Vote "Outperform" if you believe BWAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BWAY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel